Barts Cancer Institute, Queen Mary University London

About Barts Cancer Institute

Barts Cancer Institute, part of Queen Mary University London, is a leading research institution dedicated to understanding and treating cancer. Established with the vision of advancing cancer research and improving patient outcomes, the institute brings together world-class scientists and clinicians.

Our core activities include:

• Innovative Research: We focus on cutting-edge research in cancer biology, genetics, and treatment methodologies.
• Clinical Trials: The institute conducts numerous clinical trials aimed at testing new therapies and improving existing treatments.
• Education and Training: We are committed to educating the next generation of cancer researchers and healthcare professionals through comprehensive training programs.

At Barts Cancer Institute, we believe in collaboration and partnership. We work closely with hospitals, universities, and research organizations both nationally and internationally to foster innovation and share knowledge.

Our vision is to translate scientific discoveries into effective treatments that can significantly improve the lives of cancer patients. We strive to be at the forefront of cancer research, making significant contributions to the field and ensuring that our findings benefit patients as quickly as possible.

With a strong emphasis on patient-centered research, we aim to understand the unique challenges faced by cancer patients and tailor our research efforts accordingly. Our commitment to excellence drives us to continuously seek new ways to combat cancer and enhance the quality of life for those affected by this disease.